Comparative and pharmacophore model for deacetylase SIRT1

被引:52
|
作者
Huhtiniemi, Tero
Wittekindt, Carsten
Laitinen, Tuomo
Leppanen, Jukka
Salminen, Antero
Poso, Antti
Lahtela-Kakkonen, Maija
机构
[1] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland
关键词
comparative modelling; computational docking; NAD-dependent deacetylation; pharmacophore; Sir2; SirT1; sirtuins;
D O I
10.1007/s10822-006-9084-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sirtuins are NAD-dependent histone deacetylases, which cleave the acetyl-group from acetylated proteins, such as histones but also the acetyl groups from several transcription factors, and in this way can change their activities. Of all seven mammalian SirTs, the human sirtuin SirT1 has been the most extensively studied. However, there is no crystal structure or comparative model reported for SirT1. We have therefore built up a three-dimensional comparison model of the SirT1 protein catalytic core (domain area from residues 244 to 498 of the full length SirT1) in order to assist in the investigation of active site-ligand interactions and in the design of novel SirT1 inhibitors. In this study we also propose the binding-mode of recently reported set of indole-based inhibitors in SirT1. The site of interaction and the ligand conformation were predicted by the use of molecular docking techniques. To distinguish between active and inactive compounds, a post-docking filter based on H-bond network was constructed. Docking results were used to investigate the pharmacophore and to identify a filter for database mining.
引用
收藏
页码:589 / 599
页数:11
相关论文
共 50 条
  • [21] SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity
    Kang, Ji An
    Kim, Yoon Jung
    Jang, Kyu Yun
    Moon, Hye Won
    Lee, Haeseung
    Lee, Seonjeong
    Song, Hyun Kyu
    Cho, Sang Woo
    Yoo, Yoon Sun
    Han, Hye Gyeong
    Kim, Min-Ju
    Chung, Myoung Ja
    Choi, Cheol Yong
    Lee, Cheolju
    Chung, Chaeuk
    Hur, Gang Min
    Kim, You-Sun
    Jeon, Young Joo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (03): : 656 - 673
  • [22] Transcriptional activation of histone deacetylase SIRT1 by Notch1 signal
    Horio, Yoshiyuki
    Iguchi, Umefumi
    Ninomiya, Takafumi
    Tatsumi, Haruyuki
    Hisahara, Shin
    Tanno, Masaya
    Takemura, Haruo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 105P - 105P
  • [23] The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome
    Caron, Annabelle Z.
    He, Xiaohong
    Mottawea, Walid
    Seifert, Erin L.
    Jardine, Karen
    Dewar-Darch, Danielle
    Cron, Greg O.
    Harper, Mary-Ellen
    Stintzi, Alain
    McBurney, Michael W.
    FASEB JOURNAL, 2014, 28 (03): : 1306 - 1316
  • [24] The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
    Firestein, Ron
    Blander, Gil
    Michan, Shaday
    Oberdoerffer, Philipp
    Ogino, Shuji
    Campbell, Jennifer
    Bhimavarapu, Anupama
    Luikenhuis, Sandra
    de Cabo, Rafael
    Fuchs, Charles
    Hahn, William C.
    Guarente, Leonard P.
    Sinclair, David A.
    PLOS ONE, 2008, 3 (04):
  • [25] Molecular imaging of NAD plus -dependent deacetylase SIRT1 in the brain
    Xu, Yulong
    Chen, Zude
    Wey, Hsiao-Ying
    Liang, Yingxia
    Tanzi, Rudolph
    Zhang, Can
    Wang, Changning
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [26] Molecular Modelling of Resveratrol Derivatives with SIRT1 for the Stimulation of Deacetylase Activity
    Zamani, Mozhdeh
    Mokarram, Pooneh
    Jamshidi, Mehdi
    Siri, Morvarid
    Ghasemi, Hadi
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (06) : 943 - 954
  • [27] Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy
    Sundaresan, Nagalingam R.
    Pillai, Vinodkumar B.
    Gupta, Mahesh P.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 614 - 618
  • [28] The orphan nuclear receptor TLX transactivates histone deacetylase SIRT1
    Horio, Yoshiyuki
    Iwahara, Naotoshi
    Hayashi, Takashi
    NEUROSCIENCE RESEARCH, 2008, 61 : S43 - S43
  • [29] The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer
    Liu, Tao
    Liu, Pei Y.
    Marshall, Glenn M.
    CANCER RESEARCH, 2009, 69 (05) : 1702 - 1705
  • [30] SIRT1 histone deacetylase is a potential therapeutic target for human melanoma
    Nihal, M.
    Singh, C. K.
    Ndiaye, M.
    Wood, G. S.
    Ahmad, N.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 857 - 858